Literature DB >> 17452463

Regulation of P-TEFb elongation complex activity by CDK9 acetylation.

Junjiang Fu1, Ho-Geun Yoon, Jun Qin, Jiemin Wong.   

Abstract

P-TEFb, comprised of CDK9 and a cyclin T subunit, is a global transcriptional elongation factor important for most RNA polymerase II (pol II) transcription. P-TEFb facilitates transcription elongation in part by phosphorylating Ser2 of the heptapeptide repeat of the carboxy-terminal domain (CTD) of the largest subunit of pol II. Previous studies have shown that P-TEFb is subjected to negative regulation by forming an inactive complex with 7SK small RNA and HEXIM1. In an effort to investigate the molecular mechanism by which corepressor N-CoR mediates transcription repression, we identified HEXIM1 as an N-CoR-interacting protein. This finding led us to test whether the P-TEFb complex is regulated by acetylation. We demonstrate that CDK9 is an acetylated protein in cells and can be acetylated by p300 in vitro. Through both in vitro and in vivo assays, we identified lysine 44 of CDK9 as a major acetylation site. We present evidence that CDK9 is regulated by N-CoR and its associated HDAC3 and that acetylation of CDK9 affects its ability to phosphorylate the CTD of pol II. These results suggest that acetylation of CDK9 is an important posttranslational modification that is involved in regulating P-TEFb transcriptional elongation function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17452463      PMCID: PMC1951478          DOI: 10.1128/MCB.00857-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  65 in total

1.  Structure and function of a human TAFII250 double bromodomain module.

Authors:  R H Jacobson; A G Ladurner; D S King; R Tjian
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

2.  p300 requires its histone acetyltransferase activity and SRC-1 interaction domain to facilitate thyroid hormone receptor activation in chromatin.

Authors:  J Li; B W O'Malley; J Wong
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

Review 3.  Acetylation and deacetylation of non-histone proteins.

Authors:  Michele A Glozak; Nilanjan Sengupta; Xiaohong Zhang; Edward Seto
Journal:  Gene       Date:  2005-11-11       Impact factor: 3.688

4.  Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo.

Authors:  S H Chao; D H Price
Journal:  J Biol Chem       Date:  2001-06-28       Impact factor: 5.157

5.  A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness.

Authors:  M G Guenther; W S Lane; W Fischle; E Verdin; M A Lazar; R Shiekhattar
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

6.  Flavopiridol inhibits P-TEFb and blocks HIV-1 replication.

Authors:  S H Chao; K Fujinaga; J E Marion; R Taube; E A Sausville; A M Senderowicz; B M Peterlin; D H Price
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

7.  The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3.

Authors:  M G Guenther; O Barak; M A Lazar
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

8.  Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3.

Authors:  J Li; J Wang; J Wang; Z Nawaz; J M Liu; J Qin; J Wong
Journal:  EMBO J       Date:  2000-08-15       Impact factor: 11.598

9.  Domains in the SPT5 protein that modulate its transcriptional regulatory properties.

Authors:  D Ivanov; Y T Kwak; J Guo; R B Gaynor
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

10.  The histone deacetylase-3 complex contains nuclear receptor corepressors.

Authors:  Y D Wen; V Perissi; L M Staszewski; W M Yang; A Krones; C K Glass; M G Rosenfeld; E Seto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

View more
  37 in total

1.  Uncovering BRD4 hyperphosphorylation associated with cellular transformation in NUT midline carcinoma.

Authors:  Ranran Wang; Xing-Jun Cao; Katarzyna Kulej; Wei Liu; Tongcui Ma; Margo MacDonald; Cheng-Ming Chiang; Benjamin A Garcia; Jianxin You
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

2.  Deleted in breast cancer 1, a novel androgen receptor (AR) coactivator that promotes AR DNA-binding activity.

Authors:  Junjiang Fu; Jun Jiang; Jiwen Li; Shanshan Wang; Guang Shi; Qin Feng; Eileen White; Jun Qin; Jiemin Wong
Journal:  J Biol Chem       Date:  2009-01-05       Impact factor: 5.157

Review 3.  CYCLINg through transcription: posttranslational modifications of P-TEFb regulate transcription elongation.

Authors:  Sungyoo Cho; Sebastian Schroeder; Melanie Ott
Journal:  Cell Cycle       Date:  2010-05-29       Impact factor: 4.534

4.  Factor binding and chromatin modification in the promoter of murine Egr1 gene upon induction.

Authors:  Gema Tur; Elena I Georgieva; Andrés Gagete; Gerardo López-Rodas; José L Rodríguez; Luis Franco
Journal:  Cell Mol Life Sci       Date:  2010-06-26       Impact factor: 9.261

5.  Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development.

Authors:  Pan Tang; Jifa Zhang; Jie Liu; Cheng-Ming Chiang; Liang Ouyang
Journal:  J Med Chem       Date:  2021-02-22       Impact factor: 7.446

6.  BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.

Authors:  Daniela Boehm; Vincenzo Calvanese; Roy D Dar; Sifei Xing; Sebastian Schroeder; Laura Martins; Katherine Aull; Pao-Chen Li; Vicente Planelles; James E Bradner; Ming-Ming Zhou; Robert F Siliciano; Leor Weinberger; Eric Verdin; Melanie Ott
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

7.  Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes.

Authors:  Yoichi Sunagawa; Tatsuya Morimoto; Tomohide Takaya; Shinji Kaichi; Hiromichi Wada; Teruhisa Kawamura; Masatoshi Fujita; Akira Shimatsu; Toru Kita; Koji Hasegawa
Journal:  J Biol Chem       Date:  2010-01-17       Impact factor: 5.157

Review 8.  Manipulation of the host protein acetylation network by human immunodeficiency virus type 1.

Authors:  Mark Y Jeng; Ibraheem Ali; Melanie Ott
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-09-02       Impact factor: 8.250

9.  Acetylation of cyclin T1 regulates the equilibrium between active and inactive P-TEFb in cells.

Authors:  Sungyoo Cho; Sebastian Schroeder; Katrin Kaehlcke; Hye-Sook Kwon; Angelika Pedal; Eva Herker; Martina Schnoelzer; Melanie Ott
Journal:  EMBO J       Date:  2009-04-23       Impact factor: 11.598

10.  P-TEFb- the final frontier.

Authors:  Jiri Kohoutek
Journal:  Cell Div       Date:  2009-09-02       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.